Tempus ECG-Low EF vs FibriCheck
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your healthcare facility needs an FDA-cleared AI solution to screen patients aged 40 or older for signs associated with low left ventricular ejection fraction using standard 12-lead ECGs. This tool is ideal for integrating into existing clinical diagnostic workflows to aid clinicians in identifying patients at risk of heart failure for further evaluation.
View Tempus ECG-Low EF →Choose FibriCheck if…
Choose FibriCheck if you require a patient-centric, remote monitoring solution for heart rhythm detection and ongoing arrhythmia management using a smartphone. This app is best suited for empowering patients to self-monitor their heart rhythm outside of a clinical setting, with the option for healthcare providers to oversee and customize monitoring rules.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | FibriCheck |
|---|---|---|
| Pricing | Unknown | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Cloud-based (private cloud). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FibriCheckFibriCheck offers a highly accessible patient-facing mobile application that leverages a smartphone camera for monitoring, making it extremely convenient for end-users. While Tempus integrates into existing clinical workflows, FibriCheck's dual approach with a patient app and a professional portal provides broader and more flexible usability.
Clinical Value
Tempus ECG-Low EFTempus ECG-Low EF provides a diagnostic aid for a critical, often asymptomatic condition (low LVEF) using a standard 12-lead ECG in a clinical setting, potentially enabling earlier intervention for heart failure risk. FibriCheck offers valuable arrhythmia monitoring for patients, but Tempus's application addresses a more profound diagnostic gap in the clinical workflow for a severe condition.
Pricing & Value
FibriCheckFibriCheck provides transparent and detailed pricing models for both end-users and healthcare providers, including subscription options and short-term access. Tempus ECG-Low EF requires contacting the vendor for pricing, which makes it difficult to assess its value proposition without direct engagement.
Enterprise Readiness
Tempus ECG-Low EFTempus ECG-Low EF explicitly states integration into healthcare facility workflows, HIPAA compliance, BAA availability, and FDA clearance, indicating a strong focus on enterprise adoption. While FibriCheck also has HIPAA and FDA clearance and offers provider licensing, Tempus's direct emphasis on workflow integration and explicit BAA gives it a slight edge for large-scale institutional deployment.
Innovation
Tempus ECG-Low EFTempus ECG-Low EF demonstrates significant diagnostic innovation by using AI to detect signs of low LVEF from a standard 12-lead ECG, a capability that traditionally requires more complex imaging. While FibriCheck's smartphone-based PPG is also innovative for remote monitoring, Tempus's approach offers a novel diagnostic pathway for a critical cardiac condition.
Support & Docs
FibriCheckFibriCheck offers readily accessible public support resources, including a dedicated help center with FAQs and user guides for both patients and professionals. Tempus, as an enterprise solution, provides customer support to its clients via email and dedicated representatives, but FibriCheck's transparent and easily discoverable documentation and support channels for a broader user base give it an advantage in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | FibriCheck |
|---|---|---|
| Product Name | Tempus ECG-Low EF | FibriCheck |
| Company | Tempus AI | Qompium nv |
| Primary Detection Focus | Detects signs associated with low Left Ventricular Ejection Fraction (LVEF u226440%) | Detect and monitor arrhythmias (e.g., Atrial Fibrillation (AFib)) |
| Technology Used | AI software analyzes 12-lead ECG recordings | Smartphone camera-based PPG technology, AI-powered algorithm |
| Target User/Setting | Clinicians in clinical diagnostic settings at healthcare facilities, for patients 40+ years at risk of heart failure | Patients (end-users) for self-monitoring; healthcare providers and clinical centers for patient monitoring |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and FibriCheck.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or FibriCheck
Backers
Who funded each tool's parent company.